Skip to main content
Premium Trial:

Request an Annual Quote

Niagara U. Lands $10M Donation for Science, Bioinformatics Center

NEW YORK (GenomeWeb News) – Niagara University has received a pledge for $10 million to support construction of a new science building that, when built, will house a research and interdisciplinary biology center that will focus on bioinformatics and computational biology.
 
The $10 million from businessman and philanthropist B. Thomas Golisano, who is founder and chairman of payroll services firm Paychex and owner of the Buffalo Sabres hockey team, will be part of the university’s $80 million capital campaign, called “The Promise of Niagara.” The gift to the university will be presented in five installments of $2 million.
 
The funds from Golisano will help support construction of the 44,000 sq. ft. center, which will house academic and clinical partnerships with the Buffalo Medical Complex, the State University at Buffalo, Roswell Park Cancer Institute, and the Heart Center of Niagara.
 
The current capital campaign is seeking to raise $16.5 million toward the total cost of the $25 million science center, the university said in a statement.

Filed under

The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.